Fine antigenic specificities of antibodies in sera from patients with D-penicillamine-induced myasthenia gravis
Loading...
Date
Authors
Tzartos, S. J.
Morel, E.
Efthimiadis, A.
Bustarret, A. F.
D'Anglejan, J.
Drosos, A. A.
Moutsopoulos, H. A.
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Type
Type of the conference item
Journal type
peer-reviewed
Educational material type
Conference Name
Journal name
Clin Exp Immunol
Book name
Book series
Book edition
Alternative title / Subtitle
Description
A small fraction of patients with rheumatoid arthritis and other diseases on D-penicillamine treatment may develop antibodies against the acetylcholine receptor (AChR) and symptoms of myasthenia gravis (MG). The mechanism leading to this phenomenon is not known. We have studied the fine antigenic specificities of the anti-AChR antibodies in 19 D-penicillamine-induced MG (pen-MG) patients and compared them with those of antibodies from 204 idiopathic MG patients (the data for 122 obtained from earlier experiments). Antigenic specificities of the circulating antibodies were determined by the capacity of monoclonal antibodies (MoAbs), against certain determinants on the AChR, to inhibit binding of the serum antibodies to the AChR. Monoclonal antibodies against alpha, beta and gamma subunits were used. The anti-AChR antibody patterns of pen-MG patients were very similar to those of idiopathic MG patients. Antibodies to the main immunogenic region, which is located on the extracellular surface of the alpha-subunit, were the predominant group. The variations of antibody specificities in serial sera collected from individual patients at different times were usually small, as were those of idiopathic MG. These results strongly suggest that the antibody repertoire in the sera of idiopathic and pen-MG patients is very similar.
Description
Keywords
Adult, Aged, Aged, 80 and over, Antibody Formation, Arthritis, Rheumatoid/drug therapy, Binding, Competitive, Epitopes/*immunology, Female, Humans, Male, Middle Aged, Myasthenia Gravis/*chemically induced/immunology, Penicillamine/*adverse effects, Receptors, Cholinergic/immunology
Subject classification
Citation
Link
http://www.ncbi.nlm.nih.gov/pubmed/2464451
Language
en
Publishing department/division
Advisor name
Examining committee
General Description / Additional Comments
Institution and School/Department of submitter
Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής